Cite
MLA Citation
Eva MM Strijbis et al.. “The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.” Multiple sclerosis, vol. 28, 2022, pp. 1606–1619. http://access.bl.uk/ark:/81055/vdc_100156803845.0x000039
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eva MM Strijbis et al.. “The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.” Multiple sclerosis, vol. 28, 2022, pp. 1606–1619. http://access.bl.uk/ark:/81055/vdc_100156803845.0x000039